The battle for the future of derivatives trading is escalating as Wall Street's biggest exchanges take aim at a decentralized competitor generating over $700 million in annualized fees.
Back
Legacy Exchanges Target Hyperliquid Over its $700M DeFi Model
(P1) Legacy exchange operators CME Group and Intercontinental Exchange (ICE) are reportedly pressing U.S. regulators to scrutinize Hyperliquid, a fast-growing decentralized derivatives platform, over concerns its structure could enable manipulation in global oil markets and other commodities.
(P2) "These concerns are unfounded," the Hyperliquid Policy Center stated in response to the reports. The group argued that the platform's design, which publishes a complete on-chain record of every transaction in real-time, offers "enhanced market transparency" that makes it harder to use for illicit activities compared to traditional systems.
(P3) The dispute centers on Hyperliquid's novel structure and its rapid growth, with the platform generating roughly $65 million in monthly fees, an annualized run rate of nearly $780 million. On Hyperliquid, new energy markets can be created by staking 500,000 HYPE tokens, a sum valued at approximately $22.2 million.
(P4) The outcome of this clash could set a major precedent for how U.S. regulators, including the Commodity Futures Trading Commission (CFTC), approach decentralized derivatives. It highlights a fundamental conflict between the permissionless, 24/7 nature of DeFi protocols and the established, regulated frameworks governing incumbents like CME and ICE.
Hyperliquid founder Jeff Yan confirmed he has been meeting with policymakers in Washington D.C. to discuss a "regulatory path for bringing onchain derivatives markets into the US," noting the advancement of the CLARITY Act. The firm's advocacy arm argues that current U.S. law is ill-suited for markets built on public blockchains and that its real-time, open ledger provides superior tools for surveillance and investigation.
A Different Breed of Exchange
Unlike the CME or ICE, which act as neutral intermediaries matching buyers and sellers, Hyperliquid operates a structurally different model. It routes liquidity through an internal vault known as the Hyperliquidity Provider (HLP), which effectively serves as the direct counterparty for all trades on the platform.
This creates an asymmetric relationship where the HLP profits from traders' net losses and absorbs their net wins. Critics argue this creates potential conflicts, while supporters point to its efficiency. A significant portion of the platform's substantial trading fees are used to fund buybacks of the native HYPE token, creating a feedback loop that can support the token's price and attract more activity. The HYPE token was trading near $44.40 at press time, according to CoinGecko.
The debate is gaining urgency as institutional products linked to the platform emerge. Both 21Shares and Bitwise recently launched ETFs tied to Hyperliquid, with the latter's fund trading on the New York Stock Exchange, an exchange owned by ICE itself.
This article is for informational purposes only and does not constitute investment advice.
[1] ICE and CME Push U.S. Regulators to Rein In HYPE Token Energy Markets[2] Hyperliquid Policy Center pushes back against CME and ICE regulatory concerns[3] CME & NYSE Reportedly Move to Rein In Hyperliquid, But Why?[4] CME, ICE push U.S. regulators to scrutinize Hyperliquid over manipulation risks[5] Is Hyperliquid threatening oil pricing as CME Group, ICE raise alarms?
